Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077428
Status:
COMPLETED
Last Update Posted:
2013-01-24
First Post:
2004-02-10
Brief Title:
Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced Recurrent or Metastatic Adenoid Cystic Carcinoma Cancer of the Head and Neck
Sponsor:
Organization:
National Cancer Institute NCI